Table 2.
Type of toxicity among patients with treatment-related grade 3–5 toxicities (N = 70 patients)
| Toxicity type | Grade 3–4 toxicities | |
|---|---|---|
| Hematologic | ||
| Anemia | 13 | 38% |
| White blood cell count decreased | 10 | 29% |
| Neutrophil count decreased | 8 | 24% |
| Bleeding | 3 | 9% |
| Non-hematologic | ||
| Metabolic abnormalities | 14 | 12% |
| Nausea/vomiting | 13 | 11% |
| Neuropathy | 12 | 10% |
| Mucositis | 9 | 8% |
| Infection | 9 | 8% |
| Fatigue | 9 | 8% |
| Diarrhea | 6 | 5% |
| Arrhythmia | 5 | 4% |
| Left ventricular systolic dysfunction | 5 | 4% |
| Pain | 5 | 4% |
| Dehydration | 4 | 3% |
| Allergy | 3 | 2.5% |
| Hypotension | 3 | 2.5% |
| Syncope | 3 | 2.5% |
| Kidney dysfunction | 3 | 2.5% |
| Dizziness | 2 | 1.7% |
| Othersa | 1 | 0.8% |
Results are presented as number and percentage of patients
aOthers: depression, falls, dysphagia, abnormal liver enzyme, bowel perforation, constipation, sore throat, aspiration, embolism, hand-foot syndrome